Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pulse Biosciences CS (NQ: PLSE )

17.08 +1.48 (+9.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pulse Biosciences CS

< Previous 1 2 3 4 5 Next >
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pulse Biosciences, Inc. (PLSE)
From Glancy Prongay & Murray LLP
Via Business Wire
Shareholder Alert: Robbins LLP Reminds Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading Shareholders
From Robbins LLP
Via Business Wire
PLSE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Shareholder Alert: Robbins LLP Informs Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading Shareholders
From Robbins LLP
Via Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – PLSE
From The Rosen Law Firm, P.A.
Via Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Pulse Biosciences, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ALERT: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
PLSE CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Pulse Biosciences, Inc.
From Glancy Prongay & Murray LLP
Via Business Wire
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
From Pulse Biosciences, Inc.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences to Participate in the Stephens Annual Investment Conference
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Reports Third Quarter 2021 Financial Results
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021
From Pulse Biosciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.